TY - JOUR
T1 - Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans
AU - Gupta, Naren
AU - Miyauchi, Seiji
AU - Martindale, Robert G.
AU - Herdman, Anne V.
AU - Podolsky, Robert
AU - Miyake, Katsuya
AU - Mager, Sela
AU - Prasad, Puttur D.
AU - Ganapathy, Malliga E.
AU - Ganapathy, Vadivel
N1 - Funding Information:
This work was supported by the National Institutes Health grant GM 65344 (M.E.G.).
PY - 2005/6/30
Y1 - 2005/6/30
N2 - ATB0,+ (SLC6A14) is a Na+/Cl--coupled arginine transporter expressed at low levels in normal colon. Arginine is an essential amino acid for tumor cells. Arginine is also the substrate for nitric oxide synthases (NOSs). Since arginine and arginine-derived nitric oxide (NO) play a critical role in cancer, we examined the expression of ATB0,+ in colorectal cancer. Paired normal and cancer tissues from colectomy specimens of 10 patients with colorectal cancer and from the liver tissue of one patient with hepatic metastasis from a colonic primary were used for the analysis of the levels of ATB0,+ mRNA, inducible NOS (iNOS) mRNA and the corresponding proteins. Tissues samples from the colon, liver, and lymph nodes of an additional patient with metastatic colon cancer were analyzed for ATB 0,+ protein alone. We also examined the levels of nitrotyrosylated proteins. The ATB0,+ mRNA increased 22.9 ± 3.0-fold in colorectal cancer compared to normal tissue and the increase was evident in each of the 10 cases examined. iNOS mRNA increased 5.2 ± 1.1-fold in cancer specimens. The changes in mRNA levels were associated with an increase in ATB0,+, iNOS, and nitrotyrosylated proteins. The increased expression of ATB0,+ and iNOS was also demonstrated in liver and lymph node specimens with metastases from colonic primaries. This study strongly suggests that the upregulation of ATB0,+ may have a pathogenic role in colorectal cancer. Since ATB0,+ is a versatile transporter not only for arginine but also for several drugs including NOS inhibitors, these findings have significant clinical and therapeutic relevance.
AB - ATB0,+ (SLC6A14) is a Na+/Cl--coupled arginine transporter expressed at low levels in normal colon. Arginine is an essential amino acid for tumor cells. Arginine is also the substrate for nitric oxide synthases (NOSs). Since arginine and arginine-derived nitric oxide (NO) play a critical role in cancer, we examined the expression of ATB0,+ in colorectal cancer. Paired normal and cancer tissues from colectomy specimens of 10 patients with colorectal cancer and from the liver tissue of one patient with hepatic metastasis from a colonic primary were used for the analysis of the levels of ATB0,+ mRNA, inducible NOS (iNOS) mRNA and the corresponding proteins. Tissues samples from the colon, liver, and lymph nodes of an additional patient with metastatic colon cancer were analyzed for ATB 0,+ protein alone. We also examined the levels of nitrotyrosylated proteins. The ATB0,+ mRNA increased 22.9 ± 3.0-fold in colorectal cancer compared to normal tissue and the increase was evident in each of the 10 cases examined. iNOS mRNA increased 5.2 ± 1.1-fold in cancer specimens. The changes in mRNA levels were associated with an increase in ATB0,+, iNOS, and nitrotyrosylated proteins. The increased expression of ATB0,+ and iNOS was also demonstrated in liver and lymph node specimens with metastases from colonic primaries. This study strongly suggests that the upregulation of ATB0,+ may have a pathogenic role in colorectal cancer. Since ATB0,+ is a versatile transporter not only for arginine but also for several drugs including NOS inhibitors, these findings have significant clinical and therapeutic relevance.
KW - Amino acid transporter ATB
KW - Cancer
KW - Colon
KW - Nitric oxide
KW - Nitric oxide synthase
UR - http://www.scopus.com/inward/record.url?scp=20444459582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20444459582&partnerID=8YFLogxK
U2 - 10.1016/j.bbadis.2005.04.002
DO - 10.1016/j.bbadis.2005.04.002
M3 - Article
C2 - 15905073
AN - SCOPUS:20444459582
SN - 0925-4439
VL - 1741
SP - 215
EP - 223
JO - Biochimica et Biophysica Acta - Molecular Basis of Disease
JF - Biochimica et Biophysica Acta - Molecular Basis of Disease
IS - 1-2
ER -